Work

Supplementary Fig. 1 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models

Year: 2026

Type: supplementary-materials

Abstract: Supplementary Figure 1. Confocal 40x images of control conditions: negative control - no Bremachlorin, no Mitotracker® Green (left hand side); 100 µM Bremachlorin alone and no Mitotracker® Green (middle), no Bremachlorin and MitoTracker® Green alone (right hand side). From top to bottom: Bremachlorin, MitoTracker® Green, composite of Bremachlorin and MitoTracker® Green and bright field in T-cell low clones.

DOI: 10.1158/1535-7163.32713996

Authors: Roisin McMorrow, Henriette S. de Bruijn, Stefania Farina, Ruben J.L. van Ardenne, Ivo Que, Pier G. Mastroberardino, Dominic J. Robinson, Laura Mezzanotte, Clemens W.G.M. Löwik

Language: English

Topic: Photodynamic Therapy Research Studies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165015507

Cites:

Cited by:

Related to: 10